Company news

Senseonics Holdings, Inc. news in 2026

Senseonics Holdings, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results

November 9, 2026

Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component

October 26, 2026

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

October 22, 2026

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4: 30 P.M. Eastern Time

October 21, 2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense(R) 365 with the iLet(R) Bionic Pancreas

September 15, 2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

September 14, 2026

Senseonics To Participate in Upcoming Institutional Investor Conferences

September 10, 2026

Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results

August 6, 2026

Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4: 30 P.M. Eastern Time

July 21, 2026

Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365

June 9, 2026

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

June 6, 2026

SENS short-form announcement: year-end results (Short form report year end results)

June 2, 2026

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

June 1, 2026

Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results

May 7, 2026

Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 4, 2026

Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4: 30 P.M. Eastern Time

May 1, 2026

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

April 30, 2026

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

April 30, 2026

Senseonics Announces European Launch of Eversense 365, The World's First and Only One Year CGM System

April 27, 2026

Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System

April 24, 2026

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

March 13, 2026

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

March 1, 2026

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

February 19, 2026

Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

January 28, 2026

Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 28, 2026

Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update

January 11, 2026

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

January 7, 2026

Calls in 2026

Decks in 2026